Risk stratification and dental management of the patient with cardiovascular diseases. Part II: Oral disease burden and principles of dental management

Steinhauer, Tad; Bsoul, Samer A.; Terezhalmy, Geza T.
March 2005
Quintessence International;Mar2005, Vol. 36 Issue 3, p209
Academic Journal
Cardiovascular diseases are the leading cause of death in the United States and most other Western countries. In the United States alone, more than 1 million annual deaths and as many as three times that number of serious consequences can be attributed to these conditions, To provide care to patients with cardiovascular disease, oral health care providers must understand the disease, its treatment, and its impact on the patient's ability to undergo and respond to dental care.


Related Articles

  • Risk stratification and dental management of the patient with cardiovascular diseases. Part I: Etiology, epidemiology, and principles of medical management. Steinhauer, Tad; Bsoul, Samer A.; Terezhalmy, Geza T. // Quintessence International;Feb2005, Vol. 36 Issue 2, p119 

    The heart pumps blood through a system of blood vessels under the control of an electric conduction system to deliver oxygen to all cells of the body. When the blood volume becomes greater than the limited volume capacity of the vascular system, the patient develops hypertension. When the...

  • Mechanisms Linking Red Blood Cell Disorders and Cardiovascular Diseases. Mozos, Ioana // BioMed Research International;2/1/2015, Vol. 2015, p1 

    The present paper aims to review the main pathophysiological links between red blood cell disorders and cardiovascular diseases, provides a brief description of the latest studies in this area, and considers implications for clinical practice and therapy. Anemia is associated with a special risk...

  • hypertension. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p397 

    An encyclopedia entry for "hypertension" is presented. It refers to persistently raised blood pressure. A hypertensive person is said to have persistently high blood pressure even when at rest. Blood pressure is measured as two values, systolic and diastolic. Severe or accelerated hypertension...

  • Cardiovascular Comorbidities of COPD: When Do they Occur and How are they Managed? Angelakas, Angelos; Vlachopoulos, Charalambos; Ioakeimidis, Nikolaos; Aggelis, Athanasios; Aznaouridis, Konstantinos; Stefanadis, Christodoulos // Current Respiratory Medicine Reviews;Dec2013, Vol. 9 Issue 6, p384 

    Chronic obstructive pulmonary disease (COPD) is highly prevalent worldwide. Its morbidity and mortality are increasing and it is predicted to be the third leading cause of death by 2020. COPD and cardiovascular disease (CVD) are chronic conditions that share many risk factors and a complex...

  • Sleep-Disordered Breathing and Cardiovascular Disorders ... includes discussion. Budhiraja, Rohit; Budhiraja, Pooja; Quan, Stuart F. // Respiratory Care;Oct2010, Vol. 55 Issue 10, p1322 

    Compelling data demonstrate a strong association between sleep-disordered breathing (SDB) and cardiovascular disorders. The association is most consistent between obstructive sleep apnea (OSA) and hypertension. Epidemiologic and clinic-based studies provide evidence for an etiological role of...

  • Sleep apnoea syndromes and the cardiovascular system. Pepperell, Justin C. // Clinical Medicine;Jun2011, Vol. 11 Issue 3, p275 

    The article discusses various cardiovascular medical conditions that are associated with sleep apnoea syndromes. The syndromes are categorized into three main disorders namely central sleep apnoea (CSA), Cheyne-Stokes respiration (CSR) and obstructive sleep apnoea. It says that these are also...

  • Potential underdiagnosis of obstructive sleep apnoea in the cardiology outpatient setting. Costa, Lucas E.; Uchôa, Carlos Henrique G.; Harmon, Rebeca R.; Bortolotto, Luiz A.; Lorenzi-Filho, Geraldo; Drager, Luciano F. // Heart;Aug2015, Vol. 101 Issue 16, p1288 

    Introduction Consistent evidence suggests that obstructive sleep apnoea (OSA) is associated with increased cardiovascular risk. However, it is unclear whether OSA is underdiagnosed in the cardiology outpatient setting. In the present study, we prospectively evaluated the potential underdiagnosis...

  • Atrial Fibrillation: Emerging Possibilities for Drug Treatment: An Overview of Current Opportunities and Recent Developments. Papp, Julius Gy.; Singh, Bramah N. // Journal of Cardiovascular Pharmacology & Therapeutics;Jun2003 Supplement, Vol. 8 Issue 1S, pS1 

    This article focuses on the treatment of atrial fibrillation. Undoubtedly, atrial fibrillation (AF) is a major clinical and economic burden in this age of an impending global pandemic of cardiovascular disease. There is a considerable overlap between AF and ischemic heart disease, hypertension,...

  • The Role of Myocardial Collagen Network in Hypertensive Heart Disease. Díez, Javier; López, Begoña; González, Arantxa; Querejeta, Ramón // Current Hypertension Reviews;2007, Vol. 3 Issue 1, p1 

    It is time to recognize that the quality, not quantity, of myocardium in hypertensive heart disease is responsible for adverse cardiovascular events. Experimental and clinical available data indicate that myocardial fibrosis due to the exaggerated accumulation of collagen type I and type III...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics